Legal & General Group Plc Acquires 288,691 Shares of The Chemours Company $CC

Legal & General Group Plc raised its holdings in shares of The Chemours Company (NYSE:CC) by 19.7% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,752,901 shares of the specialty chemicals company’s stock after buying an additional 288,691 shares during the quarter. Legal & General Group Plc’s holdings in Chemours were worth $20,071,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in CC. MTM Investment Management LLC purchased a new stake in shares of Chemours during the 2nd quarter valued at about $27,000. SouthState Corp bought a new stake in Chemours during the first quarter worth approximately $34,000. GAMMA Investing LLC lifted its stake in shares of Chemours by 130.7% in the 2nd quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock valued at $36,000 after purchasing an additional 1,799 shares during the last quarter. FNY Investment Advisers LLC boosted its holdings in shares of Chemours by 100.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock worth $45,000 after purchasing an additional 2,000 shares during the period. Finally, CWM LLC increased its position in shares of Chemours by 34.7% during the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after purchasing an additional 1,104 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CC. Mizuho lowered their price target on Chemours from $19.00 to $18.00 and set an “outperform” rating for the company in a research report on Thursday, October 16th. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a report on Wednesday, October 8th. Zacks Research cut shares of Chemours from a “hold” rating to a “strong sell” rating in a research note on Friday, October 17th. UBS Group cut their price target on shares of Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Finally, Truist Financial decreased their price objective on shares of Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Five research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Chemours currently has a consensus rating of “Hold” and a consensus price target of $17.50.

Chemours Trading Up 2.6%

NYSE CC opened at $12.79 on Friday. The stock has a market cap of $1.92 billion, a PE ratio of -5.76 and a beta of 1.64. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $22.26. The company’s 50-day moving average price is $13.54 and its 200-day moving average price is $13.21. The company has a current ratio of 1.71, a quick ratio of 0.88 and a debt-to-equity ratio of 13.66.

Chemours (NYSE:CC) last released its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.04). The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. Chemours’s quarterly revenue was down .9% on a year-over-year basis. During the same period last year, the firm earned $0.40 earnings per share. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, November 14th. Chemours’s dividend payout ratio (DPR) is presently -15.77%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.